uniQure (QURE) Depreciation & Amortization (CF) (2016 - 2026)
uniQure (QURE) posted quarterly Depreciation & Amortization (CF) of $4.9 million for Q2 2026, up 35.18% year-over-year from $3.6 million in Q2 2025, and up 66.0% quarter-over-quarter from $3.0 million in Q1 2026.
Analysis
uniQure (QURE) Depreciation & Amortization (CF) (2016 - 2026) Analysis & Trends
uniQure's Depreciation & Amortization (CF) history runs 11 years deep, the most recent figure standing at $4.9 million for Q2 2026.
- In Q2 2026, Depreciation & Amortization (CF) rose 35.18% year-over-year to $4.9 million; the TTM figure through Jun 2026 stood at $14.5 million (down 6.67% YoY), while the FY2025 annual figure was $14.8 million, up 16.76% from the prior year.
- Depreciation & Amortization (CF) for Q2 2026 stood at $4.9 million, up from $3.0 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $4.9 million in Q2 2026, with the low at $2.0 million in Q2 2022.
- The 5-year median for Depreciation & Amortization (CF) is $2.8 million (2024), against an average of $3.1 million.
- The sharpest annual moves came in 2023 and 2026: Depreciation & Amortization (CF) surged 79.67% in 2023, then tumbled 34.7% in 2026.
- uniQure's Depreciation & Amortization (CF) stood at $2.3 million in 2022, then soared by 79.67% to $4.2 million in 2023, then increased by 4.01% to $4.4 million in 2024, then sank by 31.82% to $3.0 million in 2025, then surged by 65.22% to $4.9 million in 2026.
- Business Quant data shows QURE's Depreciation & Amortization (CF) at $4.9 million in Q2 2026, $3.0 million in Q1 2026, and $3.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 40.52 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | 4.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.91 Mn |
| Mar 31, 2026 | 2.96 Mn |
| Dec 31, 2025 | 2.97 Mn |
| Sep 30, 2025 | 3.63 Mn |
| Jun 30, 2025 | 3.63 Mn |
| Mar 31, 2025 | 4.53 Mn |
| Dec 31, 2024 | 4.36 Mn |
| Sep 30, 2024 | 2.99 Mn |
| Jun 30, 2024 | 2.67 Mn |
| Mar 31, 2024 | 2.63 Mn |
| Dec 31, 2023 | 4.19 Mn |
| Sep 30, 2023 | 2.60 Mn |
| Jun 30, 2023 | 2.59 Mn |
| Mar 31, 2023 | 2.53 Mn |
| Dec 31, 2022 | 2.33 Mn |
| Sep 30, 2022 | 2.10 Mn |
| Jun 30, 2022 | 1.98 Mn |
| Mar 31, 2022 | 2.12 Mn |
| Dec 31, 2021 | 1.85 Mn |
| Sep 30, 2021 | 1.78 Mn |